Prostate Cancer Risk and Vitamin E
To the Editor: The observation by Dr Klein and colleagues 1 that treatmentwith400IU/dof␣-tocopherolincreasedtheincidence of prostate cancer might be explained by ␣-tocopherol inducing the depletion of ␥-tocopherol. ␣-Tocopherol is 1 of the 4 forms of vitamin E that occur naturally in food (␣-, ␤-, ␥-, and ␦-tocopherol). Treatment with large doses of ␣-tocopherol reduces serum concentrations of ␥-tocopherol, thereby upsetting the natural balance of vitamin E isomers in the body.
2 Both ␣-and ␥-tocopherol have been found to inhibit the growth of human prostate cancer cells in vitro, but ␥-tocopherol was more potent.
3 In a case-control study of 10 456 men, higher blood levels of ␣-tocopherol and ␥-tocopherol were each associated with a lower risk of developing prostate cancer, but the associationwith␥-tocopherolwasstrongerthanthatof␣-tocopherol. 4 Inarandomizedcontrolledtrial,treatmentwitharelativelysmall dose of ␣-tocopherol (50 IU/d) significantly decreased the incidence of prostate cancer in a group of cigarette smokers.
5
These observations raise the possibility that both ␣-and ␥-tocopherol have a protective effect against prostate cancer. However, when ␣-tocopherol is given by itself in large doses (such as Ն400 IU/d), depleting ␥-tocopherol, the beneficial effect of ␣-tocopherol might be negated. Taking vitamin E as mixed tocopherols (containing all 4 forms of vitamin E) might not increase prostate cancer risk, and further research is needed to examine that possibility.
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